![Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - ScienceDirect Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0140673621018250-gr1.gif)
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - ScienceDirect
![Active prescription of low-dose aspirin during or prior to hospitalization and mortality in COVID-19: A systematic review and meta-analysis of adjusted effect estimates - ScienceDirect Active prescription of low-dose aspirin during or prior to hospitalization and mortality in COVID-19: A systematic review and meta-analysis of adjusted effect estimates - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1201971221004173-gr1.jpg)
Active prescription of low-dose aspirin during or prior to hospitalization and mortality in COVID-19: A systematic review and meta-analysis of adjusted effect estimates - ScienceDirect
![Frontiers | Association Between Aspirin Use and Decreased Risk of Pneumonia in Patients With Cardio-Cerebra-Vascular Ischemic Disease: A Population-Based Cohort Study Frontiers | Association Between Aspirin Use and Decreased Risk of Pneumonia in Patients With Cardio-Cerebra-Vascular Ischemic Disease: A Population-Based Cohort Study](https://www.frontiersin.org/files/MyHome%20Article%20Library/625834/625834_Thumb_400.jpg)
Frontiers | Association Between Aspirin Use and Decreased Risk of Pneumonia in Patients With Cardio-Cerebra-Vascular Ischemic Disease: A Population-Based Cohort Study
![Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study | BMC Gastroenterology | Full Text Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study | BMC Gastroenterology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12876-020-1158-y/MediaObjects/12876_2020_1158_Fig1_HTML.png)
Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study | BMC Gastroenterology | Full Text
![Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection - ScienceDirect Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1542356520305334-gr1.jpg)
Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection - ScienceDirect
![Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? | Drugs Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? | Drugs](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40265-020-01365-1/MediaObjects/40265_2020_1365_Fig1_HTML.png)
Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? | Drugs
Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection
![Cofactors and comorbidities in patients with aspirin/NSAID hypersensitivity | Allergologia et Immunopathologia Cofactors and comorbidities in patients with aspirin/NSAID hypersensitivity | Allergologia et Immunopathologia](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//03010546/0000004500000006/v1_201710301332/S0301054616301215/v1_201710301332/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNe5umqYt0zKZP4SYniTZ7+SgZrkCgayp3MRA1ovxa2vU7XiyYWZcFWkqgjpVKRJ9prmh2VbaiK3QAL5RxCGeSOZ6Y2nfVj0oVHJ2YUm0u82mPQZP3tCnN+19Sr7Mv5CjB6FsIH8cVf6AiayuHtsDbaIXOD4eq4EScVr0cm0M6FdzcS9dxAGPROW1jSKalQlu2R+QYgV5JfYbi1csMp5oWoab+uoRnb4ormCQTAOMVaiwPQQg/Fv1SIAXnDEyk68cBi4AWRKXLvqjCH1xvfgAwGt)